Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 3
2008 4
2009 3
2010 3
2011 8
2012 4
2013 13
2014 2
2015 1
2016 2
2017 1
2018 3
2019 12
2020 2
2021 2
2022 5
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
Zhanel GG, Esquivel J, Zelenitsky S, Lawrence CK, Adam HJ, Golden A, Hink R, Berry L, Schweizer F, Zhanel MA, Bay D, Lagacé-Wiens PRS, Walkty AJ, Lynch JP 3rd, Karlowsky JA. Zhanel GG, et al. Among authors: lagace wiens prs. Drugs. 2020 Feb;80(3):285-313. doi: 10.1007/s40265-020-01257-4. Drugs. 2020. PMID: 31970713 Review.
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG, Golden AR, Zelenitsky S, Wiebe K, Lawrence CK, Adam HJ, Idowu T, Domalaon R, Schweizer F, Zhanel MA, Lagacé-Wiens PRS, Walkty AJ, Noreddin A, Lynch Iii JP, Karlowsky JA. Zhanel GG, et al. Among authors: lagace wiens prs. Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2. Drugs. 2019. PMID: 30712199 Review.
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.
Zhanel GG, Cheung D, Adam H, Zelenitsky S, Golden A, Schweizer F, Gorityala B, Lagacé-Wiens PR, Walkty A, Gin AS, Hoban DJ, Karlowsky JA. Zhanel GG, et al. Drugs. 2016 Apr;76(5):567-88. doi: 10.1007/s40265-016-0545-8. Drugs. 2016. PMID: 26863149 Review.
Moving towards a standardized definition of antimicrobial resistance: a comparison of the antimicrobial susceptibility profile of difficult-to-treat resistance (DTR) versus multidrug-resistant (MDR) Pseudomonas aeruginosa clinical isolates (CANWARD, 2016-2021).
Walkty A, Karlowsky JA, Lagacé-Wiens PRS, Baxter MR, Adam HJ, Bay DC, Zhanel GG. Walkty A, et al. Among authors: lagace wiens prs. Diagn Microbiol Infect Dis. 2024 Feb;108(2):116130. doi: 10.1016/j.diagmicrobio.2023.116130. Epub 2023 Nov 17. Diagn Microbiol Infect Dis. 2024. PMID: 38006710
Influenza epidemiology--past, present, and future.
Lagacé-Wiens PR, Rubinstein E, Gumel A. Lagacé-Wiens PR, et al. Crit Care Med. 2010 Apr;38(4 Suppl):e1-9. doi: 10.1097/CCM.0b013e3181cbaf34. Crit Care Med. 2010. PMID: 20029350 Review.
68 results